References
1 Busse WW, Lemanske RF, Gern JE. Role of viral respiratory
infections in asthma and asthma exacerbations. Lancet. 2010;376 : 826–34.
2 Johnston SL, Pattemore PK, Sanderson G, et al.Community study of role of viral infections in exacerbations of asthma
in 9-11 year old children. BMJ 1995; 310 : 1225.
3 Skevaki C, Karsonova A, Karaulov A, Xie M, Renz H.
Asthma-associated risk for COVID-19 development. J Allergy Clin
Immunol 2020; 146 : 1295–301.
4 Wang Y, Ao G, Qi X, Xie B. The association between COVID‐19 and
asthma: A systematic review and meta‐analysis. Clin Exp Allergy2020; 50 : 1274–7.
5 Mendes NF, Jara CP, Mansour E, Araújo EP, Velloso LA. Asthma and
COVID-19: a systematic review. Allergy, Asthma Clin Immunol 2021;17 : 5.
6 Terry PD, Heidel RE, Dhand R. Asthma in Adult Patients with COVID-19:
Prevalence and Risk of Severe Disease. Am J Respir Crit Care Med2021; published online Jan 25. DOI:10.1164/rccm.202008-3266oc.
7 Lovinsky-Desir S, Deshpande DR, De A, et al. Asthma among
hospitalized patients with COVID-19 and related outcomes. 2020.
DOI:10.1016/j.jaci.2020.07.026.
8 Rosenthal JA, Awan SF, Fintzi J, Keswani MSCI A, Ein D. Asthma
is associated with increased risk of intubation but not hospitalization
or death in coronavirus disease 2019. Ann Allergy, Asthma Immunol2021; 126 : 93–5.
9 Broadhurst R, Peterson R, Wisnivesky JP, et al. Asthma in
COVID-19 Hospitalizations: An Overestimated Risk Factor? Ann Am
Thorac Soc 2020; 17 . DOI:10.1513/AnnalsATS.202006-613RL.
10 Zhu Z, Hasegawa K, Ma B, et al. Association of asthma and its
genetic predisposition with the risk of severe COVID-19. J Allergy
Clin Immunol 2020; : 327-329.e4.
11 Myung Yang J, Yong Koh H, Yong Moon S, et al. Allergic
disorders and susceptibility to and severity of COVID-19:
A nationwide cohort study. 2020. DOI:10.1016/j.jaci.2020.08.008.
12 Skevaki C, Karsonova A, Karaulov A, et al. SARS-CoV-2
infection and COVID-19 in asthmatics: a complex relationship. Nat. Rev.
Immunol. 2021; : 1.
13 Jackson DJ, Busse WW, Bacharier LB, et al. Association of
respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor
ACE2. J Allergy Clin Immunol 2020; 146 .
DOI:10.1016/j.jaci.2020.04.009.
14 Ferastraoaru D, Hudes G, Jerschow E, et al. Eosinophilia in
Asthma Patients Is Protective Against Severe COVID-19 Illness. J
Allergy Clin Immunol Pract 2021; published online Jan.
DOI:10.1016/j.jaip.2020.12.045.
15 Lowe HJ, Ferris TA, Hernandez PM, Weber SC. STRIDE: an integrated
standards-based translational research informatics platform. 2009; :
391–5.
16 Global Initiative for Asthma. Global Strategy for Asthma Management
and Prevention. 2020 www.ginasthma.org (accessed Jan 19, 2021).
17 National Institutes of Health. Clinical Spectrum | COVID-19
Treatment Guidelines. 2020.
https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/
(accessed Jan 19, 2021).
18 Chen Y, Gong X, Wang L, Guo J. Effects of hypertension, diabetes and
coronary heart disease on COVID-19 diseases severity: a systematic
review and meta-analysis. medRxiv 2020; published online March
30. DOI:https://doi.org/10.1101/2020.03.25.20043133.
19 Kruglikov I, Shah M, Scherer P. Obesity and diabetes as comorbidities
for COVID-19: Underlying mechanisms and the role of viral-bacterial
interactions. eLife 2020; 9. DOI: 10.7554/eLife.61330.
20 Brake SJ, Barnsley K, Lu W, McAlinden KD, Eapen MS, Sohal SS. Smoking
Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential
Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19). J Clin
Med 2020; 9 . DOI:10.3390/jcm9030841.
21 Xie G, Ding F, Han L, Yin D, Lu H, Zhang M. The role of peripheral
blood eosinophil counts in COVID‐19 patients. Allergy 2020;
published online July 13. DOI:10.1111/all.14465.
22 Lindsley AW, Schwartz JT, Rothenberg ME. Eosinophil responses during
COVID-19 infections and coronavirus vaccination. J Allergy Clin
Immunol 2020; 146 . DOI:10.1016/j.jaci.2020.04.021.
23 Choi YJ, Park J-Y, Lee HS, et al. Early View Effect of Asthma
and Asthma Medication on the Prognosis of Patients with COVID-19.
DOI:10.1183/13993003.02226-2020.
24 Schultze A, Walker AJ, MacKenna B, et al. Risk of
COVID-19-related death among patients with chronic obstructive pulmonary
disease or asthma prescribed inhaled corticosteroids: an observational
cohort study using the OpenSAFELY platform. Lancet Respir Med2020; 8 : 1106–20.
25 Bloom CI, Drake TM, Docherty AB, et al. Risk of adverse
outcomes in patients with underlying respiratory conditions admitted to
hospital with COVID-19: a national, multicentre prospective cohort study
using the ISARIC WHO Clinical Characterisation Protocol UK. Lancet
Respir Med 2021; published online March.
DOI:10.1016/S2213-2600(21)00013-8.
26 Matsuyama S, Kawase M, Nao N, et al . The Inhaled Steroid
Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral
Replication-Transcription Complex in Cultured Cells. Journal of
Virology 2020; 95. DOI: 10.1128/JVI.01648-20.
27 Peters M, Sajuthi S, Deford P, et al . COVID-19-related Genes
in Sputum Cells in Asthma. Relationship to Demographic Features and
Corticosteroids. American Journal of Respiratory and Critical Care
Medicine 2020; 202. DOI: 10.1164/rccm.202003-0821OC.
28 Finney LJ, Glanville N, Farne H, et al. Inhaled
corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD
through suppression of type I interferon. 2021.
DOI:10.1016/j.jaci.2020.09.034.
29 Carfì A, Bernabei R, Landi F. Persistent Symptoms in Patients After
Acute COVID-19. JAMA 2020; 324 .
DOI:10.1001/jama.2020.12603.
30 Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of
post-acute covid-19 in primary care. BMJ 2020; published online
Aug 11. DOI:10.1136/bmj.m3026.